Abstract
Acute lymphoblastic leukemia (ALL) is characterized by distinctive morphologic, cytogenetic, and molecular genetic features, some of which have important clinical implications for both diagnosis and predicting response to specific treatment regimens, while the role of others is yet to be defined. This chapter will describe the cytogenetic and molecular aberrations in ALL.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bloomfield CD, Secker-Walker LM, Goldman AI, et al. (1989) Sixyear follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia. Cancer Genet Cytogenet 40(2):171–185
Fenaux P, Lai JL, Morel P, et al. (1989) Cytogenetics and their prognostic value in childhood and adult acute lymphoblastic leukemia (ALL) excluding L3. Hematol Oncol 7(4):307–317
Walters R, Kantarjian HM, Keating MJ, et al. (1990) The importance of cytogenetic studies in adult acute lymphocytic leukemia. Am J Med 89(5):579–587
Hématologique GFdC (1996) Cytogenetic abnormalities in adult acute lymphoblastic leukemia: Correlations with hematologic findings outcome. A Collaborative Study of the Group Francais de Cytogenetique Hematologique. Blood 88(7):3135–3142
Secker-Walker LM, Prentice HG, Durrant J, Richards S, Hall E, Harrison G (1997) Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party. Br J Haematol 96(3):601–610
Faderl S, Kantarjian HM, Talpaz M, Estrov Z (1998) Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. Blood 91(11):3995–4019
Chessells JM, Hall E, Prentice HG, Durrant J, Bailey CC, Richards SM (1998) The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: A report from the MRC Paediatric and Adult Working Parties. Leukemia 12(4):463–473
Wetzler M, Dodge RK, Mrozek K, et al. (1999) Prospective karyotype analysis in adult acute lymphoblastic leukemia: The cancer and leukemia Group B experience. Blood 93(11):3983–3993
Gleissner B, Rieder H, Thiel E, et al. (2001) Prospective BCR-ABL analysis by polymerase chain reaction (RT-PCR) in adult acute B-lineage lymphoblastic leukemia: Reliability of RT-nested-PCR and comparison to cytogenetic data. Leukemia 15(12):1834–1840
Block AW, Carroll AJ, Hagemeijer A, et al. (2002) Rare recurring balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and acute leukemia: Report from an international workshop. Genes Chromosomes Cancer 33(4):401–412
Faderl S, Talpaz M, Estrov Z, O’Brien S, Kurzrock R, Kantarjian HM (1999) The biology of chronic myeloid leukemia. N Engl J Med 341(3):164–172
Kantarjian HM, Talpaz M, Dhingra K, et al. (1991) Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia. Blood 78(9): 2411–2418
Westbrook CA, Hooberman AL, Spino C, et al. (1992) Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: A Cancer and Leukemia Group B Study (8762). Blood 80(12):2983–2990
Melo JV, Gordon DE, Tuszynski A, Dhut S, Young BD, Goldman JM (1993) Expression of the ABL-BCR fusion gene in Philadelphia-positive acute lymphoblastic leukemia. Blood 81(10): 2488–2491
Lim LC, Heng KK, Vellupillai M, et al. (1999) Molecular and phenotypic spectrum of de novo Philadelphia positive acute leukemia. Int J Mol Med 4(6):665–667
van Rhee F, Hochhaus A, Lin F, Melo JV, Goldman JM, Cross NC (1996) p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias. Blood 87(12):5213–5217
Secker-Walker LM, Craig JM, Hawkins JM, Hoffbrand AV (1991) Philadelphia positive acute lymphoblastic leukemia in adults: Age distribution, BCR breakpoint and prognostic significance. Leukemia 5(3):196–199
Rieder H, Ludwig WD, Gassmann W, et al. (1996) Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukaemia. Br J Haematol 95(4):678–691
Ko BS, Tang JL, Lee FY, et al. (2002) Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan. Am J Hematol 71(4):291–299
Gleissner B, Gokbuget N, Bartram CR, et al. (2002) Leading prognostic relevance of the BCR-ABL translocation in adult acute Blineage lymphoblastic leukemia: A prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis. Blood 99(5):1536–54
Radich J, Gehly G, Lee A, et al. (1997) Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation. Blood 89(7):2602–2609
Thomas DA, Faderl S, Cortes J, et al. (2004) Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate. Blood 103(12):4396–4407
Preti HA, O’Brien S, Giralt S, Beran M, Pierce S, Kantarjian HM (1994) Philadelphia-chromosome-positive adult acute lymphocytic leukemia: Characteristics, treatment results, and prognosis in 41 patients. Am J Med 97(1):60–65
Thomas X, Thiebaut A, Olteanu N, et al. (1998) Philadelphia chromosome positive adult acute lymphoblastic leukemia: Characteristics, prognostic factors and treatment outcome. Hematol Cell Ther 40(3):119–128
Faderl S, Kantarjian HM, Thomas DA, et al. (2000) Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia. Leuk Lymphoma 36(3–4):263–273
Wetzler M, Dodge RK, Mrozek K, et al. (2004) Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: A study of the Cancer and Leukaemia Group B. Br J Haematol 124(3):275–288
Hu Y, Liu Y, Pelletier S, et al. (2004) Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia. Nat Genet 36(5):453–461
Yeoh EJ, Ross ME, Shurtleff SA, et al. (2002) Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1(2):133–143
Kohlmann A, Schoch C, Schnittger S, et al. (2004) Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients. Leukemia 18(1):63–71
Tkachuk DC, Kohler S, Cleary ML (1992) Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 71(4):691–700
Harrison CJ, Cuneo A, Clark R, et al. (1998) Ten novel 11q23 chromosomal partner sites. European 11q23 Workshop participants. Leukemia 12(5):811–822
Cuthbert G, Thompson K, McCullough S, et al. (2000) MLL amplification in acute leukaemia: A United Kingdom Cancer Cytogenetics Group (UKCCG) study. Leukemia 14(11):1885–1891
Ayton PM, Cleary ML (2001) Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene 20(40): 5695–5707
Strout MP, Marcucci G, Caligiuri MA, Bloomfield CD (1999) Corebinding factor (CBF) and MLL-associated primary acute myeloid leukemia: Biology and clinical implications. Ann Hematol 78(6): 251–264
Bloomfield CD, Archer KJ, Mrozek K, et al. (2002) 11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: Report from an international workshop. Genes Chromosomes Cancer 33(4):362–378
Rozovskaia T, Ravid-Amir O, Tillib S, et al. (2003) Expression profiles of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangements. Proc Natl Acad Sci 100(13):7853–7858
Armstrong SA, Staunton JE, Silverman LB, et al. (2002) MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 30(1):41–47
Tsutsumi S, Taketani T, Nishimura K, et al. (2003) Two distinct gene expression signatures in pediatric acute lymphoblastic leukemia with MLL rearrangements. Cancer Res 63(16):4882–4887
Gu Y, Nakamura T, Alder H, et al. (1992) The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell 71(4):701–708
Hilden JM, Chen CS, Moore R, Frestedt J, Kersey JH (1993) Heterogeneity in MLL/AF-4 fusion messenger RNA detected by the polymerase chain reaction in t(4;11) acute leukemia. Cancer Res 53(17):3853–3856
Biondi A, Rambaldi A, Rossi V, et al. (1993) Detection of ALL-1/AF4 fusion transcript by reverse transcription-polymerase chain reaction for diagnosis and monitoring of acute leukemias with the t(4;11) translocation. Blood 82(10):2943–2947
Yamamoto K, Seto M, Iida S, et al. (1994) A reverse transcriptasepolymerase chain reaction detects heterogeneous chimeric mRNAs in leukemias with 11q23 abnormalities. Blood 83(10): 2912–2921
Griesinger F, Elfers H, Ludwig WD, et al. (1994) Detection of HRXFEL fusion transcripts in pre-pre-B-ALL with and without cytogenetic demonstration of t(4;11). Leukemia 8(4):542–548
Uckun FM, Herman-Hatten K, Crotty ML, et al. (1998) Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation. Blood 92(3):810–821
Pui CH (1992) Acute leukemias with the t(4;11)(q21;q23). Leuk Lymphoma 7(3):173–179
Schoch C, Rieder H, Freund M, Hoelzer D, Riehm H, Fonatsch C (1995) Twenty-three cases of acute lymphoblastic leukemia with translocation t(4;11)(q21;q23): The implication of additional chromosomal aberrations. Ann Hematol 70(4):195–201
Secker-Walker LM (1998) General Report on the European Union Concerted Action Workshop on 11q23, London, UK, May 1997. Leukemia 12(5):776–778
Mitelman F, Johansson B, Mertens F (2003) Mitelman database of chromosome aberrations in cancer. http://cgap nci nih gov/Chromosomes/Mitelman
Otsuki T, Clark HM, Wellmann A, Jaffe ES, Raffeld M (1995) Involvement of CDKN2 (p16INK4A/MTS1) and p15INK4B/MTS2 in human leukemias and lymphomas. Cancer Res 55(7):1436–440
Cayuela JM, Madani A, Sanhes L, Stern MH, Sigaux F (1996) Multiple tumor-suppressor gene 1 inactivation is the most frequent genetic alteration in T-cell acute lymphoblastic leukemia. Blood 87(6):2180–2186
Dreyling MH, Bohlander SK, Le Beau MM, Olopade O (1995) Refined mapping of genomic rearrangements involving the short arm of chromosome 9 in acute lymphoblastic leukemias and other hematologic malignancies. Blood 86(5):1931–1938
Hebert J, Cayuela JM, Berkeley J, Sigaux F (1994) Candidate tumorsuppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T-but not from B-cell lineage acute lymphoblastic leukemias. Blood 84(12): 4038–4044
Chim CS, Tam CY, Liang R, Kwong YL (2001) Methylation of p15 and p16 genes in adult acute leukemia: Lack of prognostic significance. Cancer 91(12):2222–2229
Hoshino K, Asou N, Okubo T, et al. (2002) The absence of the p15INK4B gene alterations in adult patients with precursor B-cell acute lymphoblastic leukaemia is a favourable prognostic factor. Br J Haematol 117(3):531–540
Morison IM, Ellis LM, Teague LR, Reeve AE (2002) Preferential loss of maternal 9p alleles in childhood acute lymphoblastic leukemia. Blood 99(1):375–377
Behrendt H, Charrin C, Gibbons B, et al. (1995) Dicentric (9;12) in acute lymphocytic leukemia and other hematological malignancies: Report from a dic(9;12) study group. Leukemia 9(1): 102–106
Rieder H, Schnittger S, Bodenstein H, et al. (1995) dic(9;20): A new recurrent chromosome abnormality in adult acute lymphoblastic leukemia. Genes Chromosomes Cancer 13(1):54–61
Clark R, Byatt SA, Bennett CF, et al. (2000) Monosomy 20 as a pointer to dicentric (9;20) in acute lymphoblastic leukemia. Leukemia 14(2):241–246
Strehl S, Konig M, Dworzak MN, Kalwak K, Haas OA (2003) PAX5/ETV6 fusion defines cytogenetic entity dic(9;12)(p13;p13). Leukemia 17(6):1121–1123
Aissani B, Bonan C, Baccichet A, Sinnett D (1999) Childhood acute lymphoblastic leukemia: Is there a tumor suppressor gene in chromosome 12p12.3? Leuk Lymphoma 34(3–4):231–239
Montpetit A, Larose J, Boily G, Langlois S, Trudel N, Sinnett D (2004) Mutational and expression analysis of the chromosome 12p candidate tumor suppressor genes in pre-B acute lymphoblastic leukemia. Leukemia 18(9):1499–1504
Aguiar RC, Sohal J, van Rhee F, et al. (1996) TEL-AML1 fusion in acute lymphoblastic leukaemia of adults. M.R.C. Adult Leukaemia Working Party. Br J Haematol 95(4):673–677
Raynaud S, Mauvieux L, Cayuela JM, et al. (1996) TEL/AML1 fusion gene is a rare event in adult acute lymphoblastic leukemia. Leukemia 10(9):1529–1530
Kwong YL, Wong KF (1997) Low frequency of TEL/AML1 in adult acute lymphoblastic leukemia. Cancer Genet Cytogenet 98(2): 137–138
Golub TR, Barker GF, Lovett M, Gilliland DG (1994) Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77(2):307–316
Romana SP, Le Coniat M, Berger R (1994) t(12;21): A new recurrent translocation in acute lymphoblastic leukemia. Genes Chromosomes Cancer 9(3):186–191
Asakura K, Uchida H, Miyachi H, et al. (2004) TEL/AML1 overcomes drug resistance through transcriptional repression of multidrug resistance-1 gene expression. Mol Cancer Res 2(6): 339–347
Zaza G, Yang W, Kager L, et al. (2004) Acute lymphoblastic leukemia with TEL-AML1 fusion has lower expression of genes involved in purine metabolism and lower de novo purine synthesis. Blood 104(5):1435–441
Dube ID, Kamel-Reid S, Yuan CC, et al. (1991) A novel human homeobox gene lies at the chromosome 10 breakpoint in lymphoid neoplasias with chromosomal translocation t(10;14). Leukemia 78(11):2996–3003
Hatano M, Roberts CW, Minden M, Crist WM, Korsmeyer SJ (1991) Deregulation of a homeobox gene, HOX11, by the t(10;14) in Tcell leukemia. Science 253(5015):79–82
Kennedy MA, Gonzalez-Sarmiento R, Kees UR, et al. (1991) HOX11, a homeobox-containing T-cell oncogene on human chromosome 10q24. Proc Natl Acad Sci 88(20):8900–8904
Willis TG, Dyer MJ (2000) The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood 96(3): 808–822
Satterwhite E, Sonoki T, Willis TG, et al. (2001) The BCL11 gene family: Involvement of BCL11A in lymphoid malignancies. Blood 98(12):3413–3420
Fu TB, Virgilio L, Narducci MG, Facchiano A, Russo G, Croce CM (1994) Characterization and localization of the TCL-1 oncogene product. Cancer Res 54(24):6297–6301
MacLeod RA, Nagel S, Kaufmann M, Janssen JW, Drexler HG (2003) Activation of HOX11L2 by juxtaposition with 3_-BCL11B in an acute lymphoblastic leukemia cell line (HPB-ALL) with t(5;14)(q35;q32.2). Genes Chromosomes Cancer 37(1):84–91
Bernard OA, Busson-LeConiat M, Ballerini P, et al. (2001) A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia 15(10):1495–1504
Mancini M, Vegna ML, Castoldi GL, et al. (2002) Partial deletions of long arm of chromosome 6: Biologic and clinical implications in adult acute lymphoblastic leukemia. Leukemia 16(10):2055–2061
Park JG, Reddy EP (1992) Large-scale molecular mapping of human c-myb locus: c-myb proto-oncogene is not involved in 6qabnormalities of lymphoid tumors. Oncogene 7(8):1603–1609
Issa JP, Zehnbauer BA, Civin CI, et al. (1996) The estrogen receptor CpG island is methylated in most hematopoietic neoplasms. Cancer Res 56(5):973–977
Sinclair PB, Sorour A, Martineau M, et al. (2004) A fluorescence in situ hybridization map of 6q deletions in acute lymphocytic leukemia: Identification and analysis of a candidate tumor suppressor gene. Cancer Res 64(12):4089–4098
Mellentin JD, Murre C, Donlon TA, et al. (1989) The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias. Science 246(4928):379–382
Murre C, McCaw PS, Baltimore D (1989) A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56(5):777–783
Nourse J, Mellentin JD, Galili N, et al. (1990) Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 60(4):535–545
Kamps MP, Murre C, Sun XH, Baltimore D (1990) A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell 60(4):547–555
Troussard X, Rimokh R, Valensi F, et al. (1995) Heterogeneity of t(1;19)(q23;p13) acute leukaemias. French Haematological Cytology Group. Br J Haematol 89(3):516–526
Yuki Y, Imoto I, Imaizumi M, et al. (2004) Identification of a novel fusion gene in a pre-B acute lymphoblastic leukemia with t(1;19)(q23;p13). Cancer Sci 95(6):503–507
Graham DK, Dawson TL, Mullaney DL, Snodgrass HR, Earp HS (1994) Cloning and mRNA expression analysis of a novel human protooncogene, c-mer. Cell Growth Differ 5(6):647–657
Georgescu MM, Kirsch KH, Shishido T, Zong C, Hanafusa H (1999) Biological effects of c-Mer receptor tyrosine kinase in hematopoietic cells depend on the Grb2 binding site in the receptor and activation of NF-kappaB. Mol Cell Biol 19(2):1171–1181
Barber KE, Martineau M, Harewood L, et al. (2004) Amplification of the ABL gene in T-cell acute lymphoblastic leukemia. Leukemia 18(6):1153–1156
Graux C, Cools J, Melotte C, et al. (2004) Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet 36(10):1084–1089
Heinonen K, Mahlamaki E, Riikonen P, Meltoranta RL, Rahiala J, Perkkio M (1999) Acquired X-chromosome aneuploidy in children with acute lymphoblastic leukemia. Med Pediatr Oncol 32(5):360–365
Onodera N, McCabe NR, Rubin CM (1992) Formation of a hyperdiploid karyotype in childhood acute lymphoblastic leukemia. Blood 80(1):203–208
Paulsson K, Panagopoulos I, Knuutila S, et al. (2003) Formation of trisomies and their parental origin in hyperdiploid childhood acute lymphoblastic leukemia. Blood 102(8):3010–3015
Czuczman MS, Dodge RK, Stewart CC, et al. (1999) Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: Cancer and leukemia Group B study 8364. Blood 93(11):3931–3939
Harrison CJ, Moorman AV, Broadfield ZJ, et al. (2004) Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia. Br J Haematol 125(5):552–559
Garipidou V, Yamada T, Prentice HG, Secker-Walker LM (1990) Trisomy 8 in acute lymphoblastic leukemia (ALL): A case report and update of the literature. Leukemia 4(10):717–719
Cario G, Stanulla M, Fine BM, et al. (2004) Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemia. Blood 105(2):821–826
Willenbrock H, Juncker AS, Schmiegelow K, Knudsen S, Ryder LP (2004) Prediction of immunophenotype, treatment response, and relapse in childhood acute lymphoblastic leukemia using DNA microarrays. Leukemia 18(7):1270–1277
Tsukasaki K, Tanosaki S, DeVos S, et al. (2004) Identifying progression-associated genes in adult T-cell leukemia/lymphoma by using oligonucleotide microarrays. Int J Cancer 109(6):875–881
Chiaretti S, Li X, Gentleman R, et al. (2004) Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival. Blood 103(7):2771–2778
Mitchell SA, Brown KM, Henry MM, et al. (2004) Inter-platform comparability of microarrays in acute lymphoblastic leukemia. BMC Genomics 5(1):71
Holleman A, Cheok MH, den Boer ML, et al. (2004) Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N Engl J Med 351(6):533–542
Derynck R, Zhang YE (2003) Smad-dependent and Smadindependent pathways in TGF-beta family signalling. Nature 425(6958):577–584
Wolfraim LA, Fernandez TM, Mamura M, et al. (2004) Loss of Smad3 in acute T-cell lymphoblastic leukemia. N Engl J Med 351(6):552–559
Armstrong SA, Kung AL, Mabon ME, et al. (2003) Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification. Cancer Cell 3(2):173–183
Taketani T, Taki T, Sugita K, et al. (2004) FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy. Blood 103(3):1085–1088
Armstrong SA, Mabon ME, Silverman LB, et al. (2004) FLT3 mutations in childhood acute lymphoblastic leukemia. Blood 103(9):3544–3546
Paietta E, Ferrando AA, Neuberg D, et al. (2004) Activating FLT3 mutations in CD117/KIt(+) T-cell acute lymphoblastic leukemias. Blood 104(2):558–560
Brown P, Levis M, Shurtleff S, Campana D, Downing J, Small D (2004) FLT3 inhibition selectively kills childhood acute lymphoblastic leukemia cells with high levels of FLT3 expression. Blood 105(2):812–820
Ferrando AA, Look AT (2003) Gene expression profiling in T-cell acute lymphoblastic leukemia. Semin Hematol 40(4):274–280
Ferrando AA, Neuberg DS, Staunton J, et al. (2002) Gene expression signatures define novel oncogenic pathways in T-cell acute lymphoblastic leukemia. Cancer Cell 1(1):75–87
Ferrando AA, Neuberg DS, Dodge RK, et al. (2004) Prognostic importance of TLX1 (HOX11) oncogene expression in adults with Tcell acute lymphoblastic leukaemia. Lancet 363(9408): 535–536
Bernard OA, Busson-LeConiat M, Ballerini P, et al. (2001) A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia 15(10):1495–1504
Berger R, Dastugue N, Busson M, et al. (2003) t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Francais de Cytogenetique Hematologique (GFCH). Leukemia 17(9):1851–1857
Cave H, Suciu S, Preudhomme C, et al. (2004) Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: Results of EORTC studies 58881 and 58951. Blood 103(2):442–450
Ballerini P, Blaise A, Busson-Le Coniat M, et al. (2002) HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis. Blood 100(3):991–997
Weng AP, Ferrando AA, Lee W, et al. (2004) Activating mutations of NOTCH1 in human T-cell acute lymphoblastic leukemia. Science 306(5694):269–271
Pear WS, Aster JC (2004) T-cell acute lymphoblastic leukemia/lymphoma: A human cancer commonly associated with aberrant NOTCH1 signaling. Curr Opin Hematol 11(6):426–433
Beverly LJ, Capobianco AJ (2004) Targeting promiscuous signaling pathways in cancer: Another Notch in the bedpost. Trends Mol Med 10(12):591–598
Aplenc R, Lange B (2004) Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemia. Br J Haematol 125(4):421–434
Weinshilboum RM, Sladek SL (1980) Mercaptopurine pharmacogenetics: Monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 32(5):651–662
Lennard L, Lilleyman JS (1987) Are children with lymphoblastic leukaemia given enough 6-mercaptopurine? Lancet 2(8562): 785–787
Lennard L, Van Loon JA, Lilleyman JS, Weinshilboum RM (1987) Thiopurine pharmacogenetics in leukemia: Correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations. Clin Pharmacol Ther 41(1):18–25
Koren G, Ferrazini G, Sulh H, et al. (1990) Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children. N Engl J Med 323(1):17–21
Schmiegelow K, Schroder H, Gustafsson G, et al. (1995) Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology. J Clin Oncol 13(2):345–351
Krynetski EY, Schuetz JD, Galpin AJ, Pui CH, Relling MV, Evans WE (1995) A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase. Proc Natl Acad Sci 92(4):949–953
Yates CR, Krynetski EY, Loennechen T, et al. (1997) Molecular diagnosis of thiopurine S-methyltransferase deficiency: Genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med 126(8):608–614
McLeod HL, Krynetski EY, Relling MV, Evans WE (2000) Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia 14(4):567–572
Relling MV, Hancock ML, Boyett JM, Pui CH, Evans WE (1999) Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia. Blood 93(9):2817–2823
Relling MV, Rubnitz JE, Rivera GK, et al. (1999) High incidence of secondary brain tumours after radiotherapy and antimetabolites. Lancet 354(9172):34–39
Relling MV, Yanishevski Y, Nemec J, et al. (1998) Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia. Leukemia 12(3):346–352
Chiusolo P, Reddiconto G, Casorelli I, et al. (2002) Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate. Ann Oncol 13(12):1915–1918
Taub JW, Matherly LH, Ravindranath Y, Kaspers GJ, Rots MG, Zantwijk CH (2002) Polymorphisms in methylenetetrahydrofolate reductase and methotrexate sensitivity in childhood acute lymphoblastic leukemia. Leukemia 16(4):764–765
Bernbeck B, Mauz-Korholz C, Zotz RB, Gobel U (2003) Methylenetetrahydrofolate reductase gene polymorphism and glucocorticoid intake in children with ALL and aseptic osteonecrosis. Klin Padiatr 215(6):327–331
Kishi S, Griener J, Cheng C, et al. (2003) Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia. J Clin Oncol 21(16):3084–3091
Krajinovic M, Lemieux-Blanchard E, Chiasson S, Primeau M, Costea I, Moghrabi A (2004) Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia. Pharmacogenomics J 4(1):66–72
Gorlick R, Cole P, Banerjee D, et al. (1999) Mechanisms of methotrexate resistance in acute leukemia. Decreased transport and polyglutamylation. Adv Exp Med Biol 457:543–550
Belkov VM, Krynetski EY, Schuetz JD, et al. (1999) Reduced folate carrier expression in acute lymphoblastic leukemia: A mechanism for ploidy but not lineage differences in methotrexate accumulation. Blood 93(5):1643–1650
Laverdiere C, Chiasson S, Costea I, Moghrabi A, Krajinovic M (2002) Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia. Blood 100(10): 3832–3834
Krajinovic M, Costea I, Chiasson S (2002) Polymorphism of the thymidylate synthase gene and outcome of acute lymphoblastic leukaemia. Lancet 359(9311):1033–1034
Lauten M, Matthias T, Stanulla M, Beger C, Welte K, Schrappe M (2002) Association of initial response to prednisone treatment in childhood acute lymphoblastic leukaemia and polymorphisms within the tumour necrosis factor and the interleukin-10 genes. Leukemia 16(8):1437–1442
Brown L, Cheng JT, Chen Q, et al. (1990) Site-specific recombination of the tal-1 gene is a common occurrence in human T-cell leukemia. EMBO J 9(10):3343–3351
Bernard O, Lecointe N, Jonveaux P, et al. (1991) Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukemias disrupt the 5′ part of the tal-1 gene. Oncogene 6(8):1477–1488
Bernard O, Barin C, Charrin C, Mathieu-Mahul D, Berger R (1993) Characterization of translocation t(1;14)(p32;q11) in a T and in a B acute leukemia. Leukemia 7(10):1509–1513
Chen Q, Yang CY, Tsan JT, et al. (1990) Coding sequences of the tal-1 gene are disrupted by chromosome translocation in human T-cell leukemia. J Exp Med 172(5):1403–1408
Carroll AJ, Crist WM, Link MP, et al. (1990) The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: A Pediatric Oncology Group study. Blood 76(6):1220–1224
Xia Y, Brown L, Tsan JT, et al. (1992) The translocation (1;14) (p34;q11) in human T-cell leukemia: Chromosome breakage 25 kilobase pairs downstream of the TAL1 protooncogene. Genes Chromosomes Cancer 4(3):211–216
Martin-Henao GA, Sureda A (1995) Translocation (1;14)(p34;q11) and trisomy 8 in a T-cell acute lymphoblastic leukemia patient. Cancer Genet Cytogenet 79(2):177–181
Hansen-Hagge TE, Schafer M, Kiyoi H, et al. (2002) Disruption of the RanBP17/Hox11L2 region by recombination with the TCRdelta locus in acute lymphoblastic leukemias with t(5;14) (q34;q11). Leukemia 16(11):2205–2212
Inaba T, Murakami S, Oku N, et al. (1990) Translocation between chromosomes 8q24 and 14q11 in T-cell acute lymphoblastic leukemia. Cancer Genet Cytogenet 49(1):69–74
Kasai M, Aoki K, Matsuo Y, Minowada J, Maziarz RT, Strominger JL (1994) Recombination hotspot associated factors specifically recognize novel target sequences at the site of interchromosomal rearrangements in T-ALL patients with t(8;14)(q24;q11) and t(1;14)(p32;q11). Int Immunol 6(7):1017–1025
Duro D, Bernard O, Della Valle V, Berger R, Larsen CJ (1995) A new type of p16INK4/MTS1 gene transcript expressed in B-cell malignancies. Oncogene 11(1):21–29
Zutter M, Hockett RD, Roberts CW, et al. (1990) The t(10;14) (q24;q11) of T-cell acute lymphoblastic leukemia juxtaposes the delta T-cell receptor with TCL3, a conserved and activated locus at 10q24. Proc Natl Acad Sci 87(8):3161–3165
Lu M, Gong ZY, Shen WF, Ho AD (1991) The tcl-3 proto-oncogene altered by chromosomal translocation in T-cell leukemia codes for a homeobox protein. EMBO J 10(10):2905–2910
Park JK, Le Beau MM, Shows TB, Rowley JD, Diaz MO (1992) A complex genetic rearrangement in a t(10;14)(q24;q11) associated with T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer 4(1):32–40
Salvati PD, Watt PM, Thomas WR, Kees UR (1999) Molecular characterization of a complex chromosomal translocation breakpoint t(10;14) including the HOX11 oncogene locus. Leukemia 13(6):975–979
Royer-Pokora B, Loos U, Ludwig WD (1991) TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11). Oncogene 6(10):1887–1893
Fizzotti M, Chen EY, Link MP, et al. (1994) Simultaneous expression of RBTN-2 and BCR-ABL oncogenes in a T-ALL with a t(11;14)(p13;q11) and a late-appearing Philadelphia chromosome. Leukemia 8(7):1124–1130
Valge-Archer V, Forster A, Rabbitts TH (1998) The LMO1 AND LDB1 proteins interact in human T-cell acute leukaemia with the chromosomal translocation t(11;14)(p15;q11). Oncogene 17(24):3199–3202
Ziemin-van der Poel S, McCabe NR, Gill HJ, et al. (1991) Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci 88(23):10735–10739
Le Coniat M, Della Valle V, Marynen P, Berger R (1997) A new breakpoint, telomeric to TEL/ETV6, on the short arm of chromosome 12 in T-cell acute lymphoblastic leukemia. Leukemia 11(8):1360–1363
Bertness VL, Felix CA, McBride OW, et al. (1990) Characterization of the breakpoint of a t(14;14)(q11.2;q32) from the leukemic cells of a patient with T-cell acute lymphoblastic leukemia. Cancer Genet Cytogenet 44(1):47–54
Chervinsky DS, Grossi M, Kakati S, Block AW, Aplan PD (1995) Concurrent presence of inv(14)(q11q32) and t(4;11)(q21;q23) in pre-B acute lymphoblastic leukemia. Genes Chromosomes Cancer 12(3):229–236
Fisch P, Forster A, Sherrington PD, Dyer MJ, Rabbitts TH (1993) The chromosomal translocation t(X;14)(q28;q11) in T-cell prolymphocytic leukaemia breaks within one gene and activates another. Oncogene 8(12):3271–3276
Stern MH, Soulier J, Rosenzwajg M, et al. (1993) MTCP-1: A novel gene on the human chromosome Xq28 translocated to the T-cell receptor alpha/delta locus in mature T-cell proliferations. Oncogene 8(9):2475–2483
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Berlin Heidelberg
About this chapter
Cite this chapter
Wetzler, M., Mrózek, K. (2008). Molecular Biology and Genetics. In: Acute Leukemias. Hematologic Malignancies. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-72304-2_6
Download citation
DOI: https://doi.org/10.1007/978-3-540-72304-2_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-72302-8
Online ISBN: 978-3-540-72304-2
eBook Packages: MedicineMedicine (R0)